Alpha Cognition
ACOG • XNAS
Alpha Cognition is a biological products, (no disgnostic substances) company trading on XNAS, led by CEO Michael E. McFadden, with a market cap of $110.4M.
CEOMichael E. McFadden
Market Cap$110.4M
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Employees5.0
Websitealphacognition.com
Next Earnings
Upcoming earnings announcement for Alpha Cognition
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.23
Revenue Estimate
$6.0M
Earnings History
Past 6 earnings reports for Alpha Cognition
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.30Est: -$0.32 | +6.3% | $2.8MEst: $3.9M | -28.8% | — |
| Nov 13, 2025 | Q3 2025 | -$0.30Est: -$0.45 | +33.3% | $2.8MEst: $2.7M | +3.7% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.65Est: -$0.51 | -27.5% | $1.7MEst: $2.0M | -18.5% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.13Est: -$0.78 | +83.3% | $2.9MEst: $1.4M | +104.8% | 10-Q |
| Mar 31, 2025 | Q4 2024 | — | — | — | — | 10-K |
| Nov 15, 2024 | Q2 2024 | -$0.31 | — | - | — | 10-Q |